Silence Therapeutics plc Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 100.00%31.34%39.94%37.83%59.34%72.70%
EBT Margin -9,372.95%-657.80%-369.36%-270.71%-168.35%-102.79%
EBIT Margin -9,317.21%-654.26%-369.02%-281.87%-203.47%-146.38%
EBITDA Margin -9,317.21%-654.26%-369.02%-281.87%-203.47%-146.38%
Operating Margin -9,317.21%-654.26%-369.02%-281.87%-203.47%-146.38%
Net Margin -8,024.59%-593.17%-317.36%-231.46%-171.37%-104.74%
FCF Margin 704.10%-261.09%44.26%-264.22%-156.49%-156.85%
Efficiency
Assets Average 161.04M
Equity Average 19.17M11.68M19.48M24.61M78.01M
Invested Capital 26.70M11.63M11.73M27.22M21.99M134.02M
Asset Utilization Ratio 0.27
Leverage & Solvency
Interest Coverage Ratio -139.47-110.98-881.04-0.00M-24.10
Equity Ratio 0.180.66
Times Interest Earned -139.47-110.98-881.04-0.00M-24.10
Valuation
Enterprise Value -17.26M537.55M613.74M479.53M565.93M177.50M
Market Capitalization 574.71M714.92M547.37M671.69M324.83M
Return Ratios
Return on Sales -80.25%-5.94%-3.17%-2.74%-1.71%-1.05%
Return on Capital Employed -0.44%
Return on Invested Capital -2.17%-4.64%
Return on Assets -0.28%
Return on Equity -2.18%-4.64%-3.05%-2.20%-0.58%